Business

Ocumetics Begins to Manufacture Accommodating Intraocular Lenses for First-In-Human Study

(TheNewswire) Calgary, Alberta – TheNewswire - July 22, 2024 - Ocumetics...

articleOcumetics Technology CorpJuly 22, 20243/company/ocumetics-technology-corp/news/ocumetics-begins-to-manufacture-accommodating-intraocular-lenses-for-first-in-human-study
Ocumetics Begins to Manufacture Accommodating Intraocular Lenses for First-In-Human Study

About this update from Ocumetics Technology Corp

[{"type":"text","content":"Ocumetics Begins to Manufacture Accommodating Intraocular Lenses for First-In-Human Study\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Calgary, Alberta\n \n \n –\n \n \n TheNewswire -\n \n \n July 22, 2024 - Ocumetics Technology Corp. (“\n \n \n Ocumetics\n \n \n ” or the\n“\n \n \n Corporation\n \n \n ”) (\n \n \n TSXV: OTC) (OTCQB: OTCFF) (FRA:\n2QBO), a leader in vision enhancement technology, is pleased to\nannounce that its intraocular lenses are now being manufactured for\nthe upcoming first-in-human study in the Dominican Republic.\n \n \n \n \n “We are thrilled to collaborate with Bioana,\nleveraging their medical device expertise and cutting-edge\nmanufacturing facilities to bring our innovative intraocular lenses to\nlife,” said Dean Burns, CEO of Ocumetics Technology Corp.\n “Producing these lenses is a critical milestone in our mission to\nprovide clear distance and near vision after cataract\nsurgery.”\n \n \n \n \n The Ocumetics lenses promise groundbreaking\nenhancements to vision correction technology.\n \n \n Designed to provide excellent visual acuity at all distances\nand improved quality of life for patients, these lenses are set to be\nevaluated in an upcoming first-in-human clinical study in the\nDominican Republic.\n \n \n \n \n Bioana’s state-of-the-art design expertise,\nmanufacturing capabilities and commitment to excellence align\nperfectly with Ocumetics’ dedication to developing top-tier\naccommodating intraocular lenses. The initial production run will\nsupport the clinical evaluation process, providing essential data to\nensure the safety and efficacy of the Ocumetics lens.\n \n \n \n \n “We are honored to be selected by Ocumetics for this\npivotal project,” said Adriana Torres COO and Chief Engineer at\nBioana, a premier design and development firm in Monterrey, Mexico.\n “Our team is excited to apply our extensive experience in medical\ndevice manufacturing to help Ocumetics achieve their vision of\ntransforming eye care.”\n \n \n \n \n The first-in-human study in the Dominican Republic is a\ncrucial step toward bringing these innovative lenses to market. The\nstudy will evaluate the performance of the Ocumetics lenses in a\ncl...

More updates from Ocumetics Technology Corp